MORE APPROVED DRUGS

*Rivaroxaban  for acute treatment and long term secondary prevention of Venous thromboembolism
*Apixaban for the prevention of stroke and systemic arterial thrombosis in patients with non valvular Atrial Fibrillation.   Apixaban 5 mg PO BID
reduce dose to 2.5 mg if patient less than 60 kg weight
                        Creatinine >1.5
                         Age >80
*Rivaroxaban approved for atrial fibrillation at 20 mg daily if GFR >50
and  15 mg if GFR between 15 and 50
No use of Riva if GFR<15